SOLIGENIX, INC. — Director's Dealing 2009

Jul 9, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DOR BIOPHARMA INC (DORB)
CIK: 0000812796
Period of Report: 2009-07-01

Reporting Person: SCHNITTKER CHRISTOPHER P (VP ADMIN CONTROLLER)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-07-01	Stock Option (Right to Buy)	$.175	A	750000	Acquired	2019-06-30	Common Stock (750000)	Direct

Footnotes

F1: Granted stock options to purchase 750,000 shares of the Company's common stock, of which 187,000 shares vest immediately and the remainder of the options will vest on each three (3) month anniversary of the grant date at a rate of 46,875 options per quarter. The exercise price of the options equals $0.175 per share, the market price of the Company's common stock as of the close of business on July 1, 2009.